BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 3081600)

  • 21. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind study of bupropion and placebo in depression.
    Feighner JP; Meredith CH; Stern WC; Hendrickson G; Miller LL
    Am J Psychiatry; 1984 Apr; 141(4):525-9. PubMed ID: 6422779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant response and plasma concentrations of bupropion.
    Preskorn SH
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):137-9. PubMed ID: 6406443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients.
    Assalian P; Rosengarten MD; Phillips R
    J Clin Psychiatry; 1985 Mar; 46(3):90-4. PubMed ID: 2857709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.
    Ferguson JM; Mendels J; Manowitz NR
    J Clin Psychiatry; 1994 Jun; 55(6):258-63. PubMed ID: 8071282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients.
    Fabre LF; Brodie HK; Garver D; Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):88-94. PubMed ID: 6406472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
    Titievsky J; Seco G; Barranco M; Kyle EM
    J Clin Psychiatry; 1982 Nov; 43(11):454-6. PubMed ID: 7174622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of amitriptyline and bupropion on primary and secondary depression: a pilot study.
    Othmer SC; Othmer E; Preskorn SH; Mac D
    J Clin Psychiatry; 1988 Aug; 49(8):310-2. PubMed ID: 3137218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology of bupropion and imipramine in elderly depressives.
    Branconnier RJ; Cole JO; Ghazvinian S; Spera KF; Oxenkrug GF; Bass JL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):130-3. PubMed ID: 6406441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression.
    Dunner D; Myers J; Khan A; Avery D; Ishiki D; Pyke R
    J Clin Psychopharmacol; 1987 Jun; 7(3):170-2. PubMed ID: 3298327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bupropion and amitriptyline in the treatment of depressed patients.
    Chouinard G
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):121-9. PubMed ID: 6406440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled comparison of trebenzomine with doxepin as an antidepressant-anxiolytic.
    Pena-Ramos A; Muniz C; Goodman LI; Borgen LA
    J Clin Psychiatry; 1979 Feb; 40(2):104-6. PubMed ID: 368044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
    Mendels J; Kiev A; Fabre LF
    Depress Anxiety; 1999; 9(2):54-60. PubMed ID: 10207659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.